Uroguanylin prevents hepatic steatosis, mitochondrial dysfunction and fibrosis in obesity-associated NAFLD

  1. Fernández-Sáez, E.M.
  2. Losarcos, M.
  3. Becerril, S.
  4. Valentí, V.
  5. Moncada, R.
  6. Martín, M.
  7. Burrell, M.A.
  8. Catalán, V.
  9. Gómez-Ambrosi, J.
  10. Mugueta, C.
  11. Colina, I.
  12. Silva, C.
  13. Escalada, J.
  14. Frühbeck, G.
  15. Rodríguez, A.
Revue:
Metabolism: Clinical and Experimental

ISSN: 1532-8600,  0026-0495

Année de publication: 2023

Volumen: 147

Type: Article

DOI: 10.1016/J.METABOL.2023.155663 GOOGLE SCHOLAR lock_openAccès ouvert editor
La source de données: Scopus